Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statement of Stockholders' Equity (Deficit)

v3.22.1
Condensed Consolidated Statement of Stockholders' Equity (Deficit) - USD ($)
Common Stock [Member]
Equity Payable [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Loss [Member]
Accumulated Deficit [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 55,411 $ 100,862 $ 101,186,889 $ (23,446) $ (99,575,503) $ 1,744,213
Beginning balance, shares at Dec. 31, 2020 55,410,695          
Stock based compensation     228,623     228,623
Foreign currency translation adjustment       (9,678)   (9,678)
Net loss         (1,693,773) (1,693,773)
Ending balance, value at Mar. 31, 2021 $ 55,411 100,862 101,415,512 (33,124) (101,269,276) 269,385
Ending balance, shares at Mar. 31, 2021 55,410,695          
Beginning balance, value at Dec. 31, 2020 $ 55,411 100,862 101,186,889 (23,446) (99,575,503) 1,744,213
Beginning balance, shares at Dec. 31, 2020 55,410,695          
Net loss           (8,300,000)
Ending balance, value at Dec. 31, 2021 $ 55,411 100,862 102,446,921 (52,088) (107,835,287) (5,284,181)
Ending balance, shares at Dec. 31, 2021 55,410,695          
Issuance of common stock for warrant $ 3,188   2,547,365     2,550,553
Issuance of common stock for warrant, Shares 3,188,190          
Fair value of options issued with related party     6,201     6,201
Stock based compensation     589,650     589,650
Foreign currency translation adjustment       (12,895)   (12,895)
Net loss         (1,933,099) (1,933,099)
Ending balance, value at Mar. 31, 2022 $ 58,599 $ 100,862 $ 105,590,137 $ (64,983) $ (109,768,386) $ (4,083,771)
Ending balance, shares at Mar. 31, 2022 58,598,885